SeroVital Class Action Says ‘Anti­-Aging Miracle’ Works as Placebo

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

Consumers have filed a class action against a supplement maker alleging that their SeroVital “anti-aging miracle” is falsely advertised as being able to increase human growth hormone levels by 682 percent, reduce wrinkles, strengthen bones, and increase sex drive.

Lead plaintiff Raul Pizana recently filed the class action against SanMedica International LLC alleging that their SeroVital-hgh supplement is marketed with false claims.

The company allegedly advertises the supplement as an “anti-aging miracle,” but the supplement does not deliver on any of the claims.

“In short, the product is no more effective for its advertised purposes than a placebo, and is therefore worthless to California consumers who, upon information and belief, have collectively expended tens of millions of dollars or more on the product during the proposed four-year class period,” the SeroVital-hgh class action lawsuit states.

According to the class action, SanMedica claims that SeroVital can make consumers “look and feel decades – not years, but decades – younger” by increased human growth hormone levels. The hormone levels are allegedly associated with “Youthful Skin Integrity*, Lean Musculature*, Elevated Energy Production*, [and] Adipose Tissue Distribution.”

However, Pizana claims that a private investigation into the supplement’s effectiveness showed that SeroVital does not deliver on the dramatic claims it advertises.

The plaintiff says he hired endocrinology experts Dr. Shlomo Melmed and Dr. David H. Madoff, who allegedly found that the supplement cannot increase human growth hormone levels by 682 percent or provide other benefits. Dr. Melmed is the head of Cedars Sinai Medical Center’s pituitary department in Los Angeles and Dr. Madoff is a professor at The John Hopkins University School of Medicine.

The SeroVital-hgh anti-aging class action states that multiple studies have reached the same conclusion as Pizana’s professional study. Pizana also states that the Federal Trade Commission made a statement that human growth hormone supplements, such as SeroVital, do not have the same effect as prescription human growth hormone injections.

The SeroVital-hgh false advertising class action lawsuit also claims that SanMedica’s own study shows that the supplement is no better than a placebo. The company allegedly highlights aspects of their own studies to give consumers a false impression of the supplement’s effectiveness. Pizana says that SanMedica did not publish their study in a peer-reviewed journal to avoid further scrutiny.

“Incredibly, upon information and belief, Defendants have sold tens of millions of dollars or more worth of the Product to California consumers based upon the false promises and misleading advertisements described herein,” the SeroVital class action lawsuit states.

Pizana seeks to represent a Class of California residents who purchased SeroVital since May 9, 2014. The class action seeks punitive damages, restitution, disgorgement, court costs, and attorneys’ fees.

Pizana is represented by Ryan J. Clarkson, Shireen M. Clarkson and Bahar Sodaify of Clarkson Law Firm PC and Annick M. Persinger of Tycko & Zavareei LLP.

The SeroVital Anti-Aging Miracle Class Action Lawsuit is Pizana v. SanMedica International LLC, et al., Case No. 1:18­-cv-­00644, in the U.S. District Court for the Eastern District of California.